Guinea vs SEAR: Hepatitis B surface antigen (HBsAg) prevalence
Guinea
2.8%
in 2024
SEAR
0.2%
in 2024
Guinea rank
7th
SEAR rank
5th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Guinea
- SEAR
How they compare
Guinea currently reports 2.8% against 0.2% in SEAR, a difference of 2.6%.
That makes Guinea's figure about 14.0 times SEAR's.
Across all 10 years both countries report, Guinea has been ahead every year.
Guinea ranks 7th and SEAR ranks 5th of 194 countries.
Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | SEAR | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.7% | 0.4% | 2.3% | Guinea |
| 2020s | 2.7% | 0.3% | 2.5% | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Guinea or SEAR?
- Guinea, at 2.8% against 0.2% in SEAR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Guinea and SEAR?
- 2.6%, with Guinea ahead.
- How many years of comparable data are there for Guinea and SEAR?
- 10 years are reported by both, from 2015 to 2024.
- How do Guinea and SEAR rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Guinea ranks 7th and SEAR ranks 5th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.